MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 581895 | Name: Glyco-lipid

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Glycolipids are lipids with a carbohydrate attached by a glycosidic (covalent) bond. Their role is to maintain the stability of the cell membrane and to facilitate cellular recognition, which is crucial to the immune response and in the connections that allow cells to connect to one another to form tissues.

Chemical Structure

Glyco-lipid
Glyco-lipid
CAS#6379-54-0

Theoretical Analysis

MedKoo Cat#: 581895

Name: Glyco-lipid

CAS#: 6379-54-0

Chemical Formula: C32H60O14

Exact Mass: 668.3983

Molecular Weight: 668.82

Elemental Analysis: C, 57.47; H, 9.04; O, 33.49

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Glyco-lipid; Glyco lipid; Glycolipid.
IUPAC/Chemical Name
Decanoic acid, 3-((tetrahydro-3,5-dihydroxy-6-methyl-4-((tetrahydro-3,4,5-trihydroxy-6-methylpyran-2-yl)oxy)pyran-2-yl)oxy)-, ester with 3-hydroxydecanoic acid, monohydrate
InChi Key
HVCOBJNICQPDBP-UHFFFAOYSA-N
InChi Code
InChI=1S/C32H58O13.H2O/c1-5-7-9-11-13-15-21(17-23(33)34)43-24(35)18-22(16-14-12-10-8-6-2)44-32-29(40)30(26(37)20(4)42-32)45-31-28(39)27(38)25(36)19(3)41-31;/h19-22,25-32,36-40H,5-18H2,1-4H3,(H,33,34);1H2
SMILES Code
[H]O[H].CCCCCCCC(OC(CC(OC1C(O)C(OC2C(O)C(O)C(O)C(C)O2)C(O)C(C)O1)CCCCCCC)=O)CC(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 668.82 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Daviddi G, Ricci MA, De Vuono S, Gentili A, Boni M, Lupattelli G. Folate and Vitamin B12 in Morbid Obesity: The Influence of Folate on Anti-Atherogenic Lipid Profile. Int J Vitam Nutr Res. 2019 Mar 4:1-7. doi: 10.1024/0300-9831/a000538. [Epub ahead of print] PubMed PMID: 30829139. 2: King LA, Lameris R, de Gruijl TD, van der Vliet HJ. CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond. Front Immunol. 2018 Jul 2;9:1519. doi: 10.3389/fimmu.2018.01519. eCollection 2018. Review. Erratum in: Front Immunol. 2018 Nov 20;9:2606. PubMed PMID: 30013569; PubMed Central PMCID: PMC6036112. 3: Baier JL, Mattner J. Mechanisms of autoimmune liver disease. Discov Med. 2014 Nov;18(100):255-63. Review. PubMed PMID: 25425466. 4: Nau D, Altmayer N, Mattner J. Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation. J Immunol Res. 2014;2014:546596. doi: 10.1155/2014/546596. Epub 2014 May 28. Review. PubMed PMID: 24987710; PubMed Central PMCID: PMC4058452. 5: Shin JH, Park SH. B Cells Promote Th1- Skewed NKT Cell Response by CD1d-TCR Interaction. Immune Netw. 2013 Oct;13(5):218-21. doi: 10.4110/in.2013.13.5.218. Epub 2013 Oct 26. PubMed PMID: 24198748; PubMed Central PMCID: PMC3817304. 6: Ikeda M, Ueno S, Matsumoto S, Shimizu Y, Komatsu H, Kusumoto K, Hamachi I. Three-dimensional encapsulation of live cells by using a hybrid matrix of nanoparticles in a supramolecular hydrogel. Chemistry. 2008;14(34):10808-15. doi: 10.1002/chem.200801144. PubMed PMID: 18942699. 7: Faveeuw C, Mallevaey T, Trottein F. Role of natural killer T lymphocytes during helminthic infection. Parasite. 2008 Sep;15(3):384-8. Review. PubMed PMID: 18814711. 8: Ikeda M, Shimizu Y, Matsumoto S, Komatsu H, Tamaru S, Takigawa T, Hamachi I. Mechanical reinforcement of a supramolecular hydrogel comprising an artificial glyco-lipid through supramolecular copolymerization. Macromol Biosci. 2008 Nov 10;8(11):1019-25. doi: 10.1002/mabi.200800061. PubMed PMID: 18576398. 9: Bonnet S, Pêtres S, Holm I, Fontaine T, Rosario S, Roth C, Longacre S. Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate. Vaccine. 2006 Aug 14;24(33-34):5997-6008. Epub 2006 Jun 5. PubMed PMID: 16814434. 10: Wimmer N, Robinson JA, Gopisetty-Venkata N, Roberts-Thomson SJ, Monteith GR, Toth I. Anti-proliferative effects of novel glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells. Med Chem. 2006 Jan;2(1):79-87. PubMed PMID: 16787358. 11: Trottein F, Mallevaey T, Faveeuw C, Capron M, Leite-de-Moraes M. Role of the natural killer T lymphocytes in Th2 responses during allergic asthma and helminth parasitic diseases. Chem Immunol Allergy. 2006;90:113-27. Review. PubMed PMID: 16210906. 12: Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996 Dec 1;56(23):5309-18. Review. PubMed PMID: 8968075. 13: Ghidoni R, Houri JJ, Giuliani A, Ogier-Denis E, Parolari E, Botti S, Bauvy C, Codogno P. The metabolism of sphingo(glyco)lipids is correlated with the differentiation-dependent autophagic pathway in HT-29 cells. Eur J Biochem. 1996 Apr 15;237(2):454-9. PubMed PMID: 8647085. 14: Kusama M, Kimura K, Koyanagi Y, Tsuchida A, Yoshimatsu A, Ebinara Y. [A case report of atypical Fabry's disease with colon cancer]. Nihon Geka Gakkai Zasshi. 1993 Jul;94(7):755-7. Japanese. PubMed PMID: 8361476. 15: Cicco G, Pirrelli A. [Glyco-lipid changes in hypertensive diabetic patients undergoing treatment with nifedipine and captopril]. Minerva Med. 1993 Mar;84(3):119-24. Italian. PubMed PMID: 8492963. 16: Burdick L, Mangiarotti R, Pini C, Fasoli A. [Effects of etozoline in patients with acute cardiac failure]. Minerva Med. 1991 Nov;82(11):749-52. Italian. PubMed PMID: 1766576. 17: Bonetti A, Campana M, Cerioli GC, Solito F, Tirelli F, Zuliani U. [Acute administration of calcium antagonists: effects on various parameters of glyco-lipid metabolism]. G Clin Med. 1987 May;68(5):289-92. Italian. PubMed PMID: 3305123. 18: Passeri M, Provvedini D. [Vitamin E in geriatric physiopathology]. Acta Vitaminol Enzymol. 1983;5(1):53-63. Review. Italian. PubMed PMID: 6342346. 19: Ferlito S, Di Mauro C, Costa A, Branca S, Raudino M. [The effect of physical exercise on the glyco-lipid effect in normal and diabetic subjects]. G Clin Med. 1980 Oct;61(10):728-39. Italian. PubMed PMID: 7016646. 20: Camarri E, Marcolongo R, Marini G, Zaccherotti L. [Results and prospects of therapy of type IV dyslipidemia with chenic acid]. Minerva Med. 1978 May 9;69(23):1561-74. Italian. PubMed PMID: 210428.

View History

Kitasamycin tartrate

Kitasamycin tartrate